Announcement of the State Food and Drug Administration on the issuance of 3 supplementary inspection methods including the supplementary inspection method for the pseudo-ginsenoside F11 inspection item in Ginseng Yangrong Pills (202

According to the relevant provisions of the "Drug Administration Law of the People's Republic of China" and its implementation regulations, "Supplementary Inspection Method for the F11 Inspection Item of Ginsenoside in Ginseng Yangrong Pills (Da Mi Pills, Xiao Mi Pills, Shui Mi Pills)" and "Feng Tong An Capsules" The Supplementary Inspection Method for the Inspection Items of Aristolochic Acid I and the Supplementary Inspection Method for the Inspection Items of the Cowhide Source in Aguiyang Blood Sugar Syrup have been approved by the State Drug Administration and are hereby issued
.
Hereby announce
.
Attachment: 1.
Supplementary inspection method for ginsenoside F11 check item in Ginseng Yangrong Pills (Da Mi Pill, Xiao Mi Pill, Shui Mi Pill) 2.
Supplementary inspection method for aristolochic acid I component inspection item in Fengtong'an Capsule 3.
Supplementary inspection method for the inspection items of cowhide source components in Aguiyang blood glucose syrup.
State Food and Drug Administration May 21, 2021, State Drug Administration Announcement No.
72, 2021 Annex 1.
doc State Drug Administration Announcement No.
72, 2021 Attachment 2.
doc Announcement No.
72 of 2021 of the National Medical Products Administration Attachment 3.
doc